NEW YORK — For the first time in history, a space shuttle is landing aboard an aircraft carrier, but instead of catching an arresting wire at high speed, the winged orbiter will be slowly lowered onto the flight deck by crane.
Read the original:
Space Shuttle Enterprise Lands at New York City's Intrepid Museum
LAS VEGAS, NV and NEW YORK, NY--(Marketwire -06/06/12)- The Cosmopolitan of Las Vegas Hotel and LUCKYRICE, an annual New York culinary festival that gives voice to Asian cultures through the lens of food and drink, will launch the LUCKYRICE Vegas Night Market on June 23 from 8 - 11p.m. with an exclusive VIP experience from 7 - 8 p.m. at the Boulevard Pool. Tickets to the event are on sale now at http://www.cosmopolitanlasvegas.com. More information about the event and the participants can be found at http://www.luckyrice.com. Tickets are priced at $88, with a limited amount of VIP tickets available for $125, which includes early access to the event.
Presented by Bombay Sapphire and Cond Nast Traveler, the LUCKYRICE Vegas Night Market will offer a variety of Asian street foods and flavors from 20 participating chefs including LUCKYRICE Culinary Council members Susur Lee (Top Chef Masters / Lee, Toronto), Pichet Ong (Qi, New York) and Angelo Sosa (Top Chef All-Stars / Social Eatz, New York) as well as renown Asian cuisine chefs from around the country such as Sang Yoon (Lukshon, Los Angeles), Jordan Kahn (Red Medicine, Los Angeles), Dale Talde (Top Chef / Talde, New York), Eddie Huang (Baohaus, New York), Jet Tila (The Charleston, Los Angeles), Paul Qui (Top Chef Texas Winner / Uchi, Austin) and Charles Phan (Slanted Door, San Francisco). In addition, the event will feature celebrated local chefs from Las Vegas including Saipin Chutima (Lotus of Siam), Colin Fukunaga and Robert "Mags" Magsalin (Fukuburger), Takashi Segawa (Monta) and Mitsuo Endo (Raku) along with The Cosmopolitan of Las Vegas's David Myers (Comme a), Shirley Chung (China Poblano by Jos Andrs), Anthony Meidenbauer (Holsteins) and Stephen Hopcraft (STK Las Vegas), Gerald Chin (Wicked Spoon).
In addition to food prepared by these chefs, the LUCKYRICE Night Market will serve culinary cocktails featuring Bombay Sapphire East created by an acclaimed team of bartenders including Tony Abou-Ganim, Duggan McDonnell (Cantina, San Francisco) and The Cosmopolitan of Las Vegas's resident mixologists Mariena Mercer, Christopher Hopkins and Jerry Vargas.
"The LUCKYRICE Festival expansion taps into America's heightened interest in Asian cuisine as increasing travel to and trade with Asia results in growing consumer awareness of Asian cultures and flavors. With so many participating restaurants and chefs, the LUCKYRICE Festival allows attendees to eat their way across Asia without leaving The Cosmopolitan of Las Vegas," says LUCKYRICE founder Danielle Chang.
ABOUT COSMOPOLITAN OF LAS VEGAS Situated at the heart of the Las Vegas Strip, The Cosmopolitan of Las Vegas is located at 3708 Las Vegas Blvd. South directly between CityCenter and the Bellagio. The resort's uniquely vertical multi-tower design offers spectacular views of the vibrant city. The new 2,995-room resort features oversized residential-style living spaces with expansive, one-of-a-kind private terraces. Resort features include 100,000 square feet of casino space; 60,000 square feet of world class shopping; 43,000 square feet of spa, health club and salon offerings; three unique pool experiences and multi-level integrated nightclubs. Signature restaurants include: Jaleo and China Poblano restaurants by Chef Jos Andrs, Blue Ribbon Sushi Bar & Grill by restaurateurs Bruce and Eric Bromberg; Comme a by Los Angeles Chef David Myers; New York City's Estiatorio Milos by restaurateur Costas Spiliadis; Holsteins from Block 16 Hospitality; Scarpetta and D.O.C.G. by award-winning Chef Scott Conant; and popular steakhouse STK from The ONE Group.
ABOUT LUCKYRICE LUCKYRICE is a culinary marketing agency that produces the annual LUCKYRICE Festival in New York. From our home base in downtown Manhattan, we work with hundreds of chefs and restaurants as well as corporate and culinary partners to bring the diverse worlds of Asian culinary culture to global-minded North American consumers. http://www.luckyrice.com.
LUCKYRICE CULINARY COUNCIL Daniel Boulud, Anthony Bourdain, Floyd Cardoz, David Chang, Michael "Bao" Huynh, Susur Lee, Anita Lo, Masaharu Morimoto, Pichet Ong, Tadashi Ono, Zakary Pelaccio, Eric Ripert, Marcus Samuelsson, Angelo Sosa, Albert Trummer, and Jean-Georges Vongerichten.
See the rest here:
EDITORIAL
In the face of high emotion over the Constitution Court's order for parliament to temporarily put off the final deliberation of the charter amendment bill scheduled for tomorrow, it is indeed a welcome relief that common sense has prevailed.
Somsak Kiatsoranont, the House speaker and parliament president, has decided to put off the debate, as the court ordered, which should avert messy protests which were threatened if the parliament defied the court order and put the bill to its third reading.
This was not an easy decision for him to make.
On one hand if he chose to defy the court, he would risk breaching Section 216 of the constitution which says the Constitution Court's decisions are final and binding on the parliament, the cabinet, the courts and other state organisations.
On the other hand, if he chose to obey the court's order to delay deliberation of the charter amendment bill, then the final reading of the bill could be delayed beyond the 15-day period specified in Section 291 of the constitution.
Thanks to a cool head and common sense, Mr Somsak chose the second option which might go against the wishes of many Pheu Thai Party MPs and their supporters who are yearning for a showdown with the court, but is the more sensible choice nonetheless.
He said the joint sitting of the House and Senate would be held tomorrow as planned but they would not consider or vote on the charter amendment bill.
Mr Somsak's decision must be respected by all, especially the United Front for Democracy Against Dictatorship whose leader, Tida Tawornseth, has threatened to lead a crowd of between 30,000-40,000 red shirt followers to gather in front of parliament tomorrow.
The threatened "show of force" by the red shirts is unnecessary if their real aim is to submit to Senate Speaker Thiradej Meepian a petition seeking the impeachment of the seven charter court judges who issued the ruling asking the house to delay the debate.
View post:
05-06-2012 23:43 Pre-ingress coverage from NASA Headquarters in Washington, DC, of the last-in-a-lifetime event.
See more here:
June 6, 2012 - NASA's Johnson Space Center has partnered with Houston Independent School District's Booker T. Washington High School to enable students in school's engineering magnet program to work on NASA projects associated with Astromaterials Research and Exploration Science Directorate through HUNCH program. Students will learn about and study realistic problems related to NASA's spaceflight and research programs, and create hardware prototypes and simulated space hardware for NASA's review and use. NASA NASA Ames Reseach Center Moffett Field, CA, 94035 USA Press release date: May 23, 2012
HOUSTON, -- NASA's Johnson Space Center has partnered with the Houston Independent School District's Booker T. Washington High School to inspire the next generation of explorers through hands-on science and engineering projects.
The partnership will enable students in the school's engineering magnet program to work on NASA projects associated with the Astromaterials Research and Exploration Science (ARES) Directorate through the High School Students United with NASA to Create Hardware, or HUNCH, program.
Through the program, students will have the opportunity to learn about and study realistic problems related to NASA's spaceflight and research programs and to create hardware prototypes, simulated space hardware, research results or other solutions for NASA's review and use. Students are currently developing a high-altitude suborbital rocket that will fly a NASA-provided micro-camera. The project will help NASA demonstrate the first steps for economical exploration-focused observation missions above the majority of Earth's atmosphere. They also are working on an interface compatible with Robonaut 2 for a surface reflectance spectrometer as part of the Moon Mars Analog Mission Activities program. The spectrometer will help provide mineralogical content of rock samples.
"Working with the Booker T. Washington High School for Engineering Professions gives JSC and ARES the opportunity to help guide the development and test of prototype equipment the students have built for our science instruments. Having the next generation of engineers and scientists with real build experience gives us a very positive outlook for the future," said Eileen K. Stansbery, Director of the ARES Directorate at Johnson.
Washington High School educates a high percentage of economically disadvantaged students. Through NASA, magnet program students will be able to access a variety of tools and raw materials, and gain insight into the kinds of projects and pressures that career engineers and scientists may face.
HUNCH is an instructional partnership between NASA, high schools and intermediate/middle schools which benefits both NASA and students. NASA receives cost- effective hardware and soft goods that are fabricated by the students. The students receive hands-on experiences and, in some cases, NASA certification in the development of training hardware for the International Space Station crew members or ground support personnel.
For more information on HUNCH or other NASA education programs, visit: http://www.nasa.gov/education
NASA Johnson Space Center news releases and other information are available automatically by sending an Internet electronic mail message to listserv@listserver.jsc.nasa.gov. In the body of the message (not the subject line) users should type "subscribe hsfnews" (no quotes). This will add the email address that sent the subscribe message to the news release distribution list. The system will reply with a confirmation via E-mail of each subscription. Once you have subscribed you will receive future news releases via e-mail.
Web Site: http://www.nasa.gov
View original post here:
The near-Earth asteroid Eros is seen from the NEAR spacecraft at a distance of 127 miles, March 3, 2000.
NASA / AP
Of all the things you don't give a hoot about, the weight of asteroid 1999 RQ36 would probably rank high. But suppose you knew that the giant space rock is predicted to have eight close and potentially deadly encounters with Earth from 2169 to 2199. Suppose you knew that calculating its exact weight and mass will help scientists better track its path, not to mention determine how bad the damage would be if we actually did get clobbered. Would you care then?
If so, be happy that investigators affiliated with NASA have indeed figured out how to take the measure 1999 RQ36 and have successfully calculated its more or less exact weight. That raises two questions: what exactly does an asteroid weigh and how in the world did the astronomers figure it out in the first place?
(PHOTOS: Views of the Asteroid Vesta)
Asteroid 1999 RQ36, which measures 1,800 ft. (560 m) across, is what's known as a near-Earth asteroid, one that, as its name suggests, does not stay safely within the massive river of rubble between Mars and Jupiter known as the asteroid belt. Rather, it follows an egg-shaped orbit around the sun swooping as close as 83 million miles (133 million km) to the solar fires and soaring as far as 126 million mi. (202 million km) away. That takes it directly across Earth's rounder, 93 million mi. (150 million km) orbit twice on each trip: once on the asteroid's way in and once on its way out. That, in turn, is more than enough to earn the rock a place in NASA's Near-Earth Objects Observation program better known as Spaceguard a sort of watch list that keeps a telescopic eye on any asteroid that poses even a theoretical threat to the planet.
The first step in determining the weight of 1999 RQ36 was determining its precise trajectory over time. The path an orbiting object follows will be partly determined by its mass and partly by the gravitational tug of any objects nearby. In the case of 1999 RQ36, those objects include the sun, moon, planets and other asteroids. Using data gathered in 2011 by the Aricebo Observatory in Puerto Rico as well as other observations conducted in 1999 and 2005 by the Goldstone Observatory in California's Mojave Desert, astronomer Steve Chesley of NASA's Jet Propulsion Laboratory in Pasadena minutely tracked 1999 RQ36's orbit over the past 12 years. His next step was to tease out all of the gravitational effects to determine how the rock would be flying based on its mass alone. Once he did that, he found that the path of 1999 RQ36 deviated from what the mathematical model said it should be by a cumulative 100 mi. (160 km).
(VIDEO: Dawn's Virtual Flight Over Vesta)
In the vastness of space, 100 miles over 12 years is less than a rounding error it's practically nothing at all. But practically nothing is not absolutely nothing, and clearly something was nudging the asteroid. The likely explanation was a phenomenon known as the Yarkovsky effect the faint propulsive power produced when an object like an asteroid absorbs sunlight and re-emits it as heat. When Chelsey re-crunched his numbers, he found there was a Yarkovsky effect pushing the asteroid alright, but an almost surreally tiny one.
"At its peak," he says, "when the asteroid is nearest the sun, the Yarkovsky force on 1999 RQ36 is about half an ounce around the weight of three grapes."
Here is the original post:
She says the next big thing is really small. In fact, its the title of her best-selling book on nanotechnology, and its a message that Deb Newberry will share with area interested learners during a fun-packed day in Rushford this Saturday.
All are invited to explore the world of nanotechnology on June 9 at Rushford-Peterson High School. Starting at 1 p.m., the Nanotechnology Conference promises the chance to learn more about the growing industry, and even have the chance to see how an atomic force microscope works.
According to the National Science Foundation (NSF), two million nanotechnology technicians will be needed over the next 15 years, with between 800,000 and one million needed by employers in the U.S. More than half of all new products will be developed with nanotechnology by 2015, estimates the NSA, which has also provided two grants to Southeast Technical for its nanotechnology program.
The conference runs from 1 p.m. until 4:30 p.m. At 1 p.m., author Deb Newberry, a consultant with the industry with 23 years of experience, will speak. She is currently director of the Nanocience Technology program at Dakota County Technical College.
Breakout sessions will be offered from 2 p.m. until 3:30 p.m., including topics such as patents and changes in law, nanotechnology and business, and rural nanotechnology. Speakers will include James Cardel, patent attorney; Kevin Klungtvedt, chairman of the Rushford Institute of Nanotechnology; Jack Weimerskirch, Goodview Mayor; and Marc Kalis, instructor at Southeast Technical. At 3:30 p.m. attendees can tour the Rushford Institute of Nanotechnology, as well as observe an atomic force microscope demonstration.
From 7 a.m. until noon, families are encouraged to bike the Root River Trail as part of the event, with tee-shirts provided for the third annual Nanotek Bicycle Trek.
For more information or to register, visit http://www.southeastmn.edu/nanotech.
Read the rest here:
Public release date: 6-Jun-2012 [ | E-mail | Share ]
Contact: Garth Hogan ghogan@asmusa.org American Society for Microbiology
Washington, DCJune 6, 2012 Myron M. Levine, M.D., D.T.P.H. has been honored with the Maurice Hilleman/Merck Award, ASM's premier award for major contributions to pathogenesis, vaccine discovery, vaccine development, and control of vaccine-preventable diseases. "Levine pioneered molecular approaches to develop attenuated recombinant Salmonella Typhi and Shigella as live oral vaccines and as live vectors," described his nominator, Harriet Robinson of GeoVax, Inc. "For decades he has engaged in the gamut of vaccine research, including epidemiologic field studies that quantify disease burden, basic laboratory efforts to engineer candidate vaccines, early clinical trials to assess vaccine safety and immunogenicity, large-scale controlled field trials to assess vaccine efficacy, and measurement of public health impact following the introduction of vaccines."
Levine is currently Director of the Center for Vaccine Development (CVD), which he co-founded in 1974, of the University of Maryland School of Medicine. He is also Head of the Division of Geographic Medicine and Betsy & Simon Grollman Distinguished Professor, both in the Department of Medicine, and a Professor in the Departments of Pediatrics, Microbiology & Immunology, and Epidemiology & Public Health.
Levine received his M.D. from the Medical College of Virginia and his D.T.P.H. from the London School of Hygiene & Tropical Medicine, and is board certified in pediatrics and preventive medicine. His extensive time at the University of Maryland includes over twenty years (1984-2005) as Head of the Division of Infectious Diseases & Tropical Pediatrics.
Levine, an advocate for mucosal immunization, has made seminal contributions in basic vaccinology, bacterial pathogenesis, clinical research, field epidemiology and public health. His laboratory research has focused on construction and characterization of attenuated strains of Salmonella Typhi, S. Paratyphi A, non-typhoidal Salmonella serovars and Shigella to serve as live oral vaccines and as live vectors for the expression of foreign antigens. He has applied his extensive experience working on the epidemiology and prevention of infectious diseases in developing countries to his research on pathogenesis and the development and testing of vaccines. He has 42 years of involvement in the conduct of Phase 1, 2, 3 and 4 clinical trials to evaluate the safety, immunogenicity and efficacy of a wide array of vaccines and has pioneered clinical trials in developing countries, including vaccines developed at the CVD. He designed and supervised the performance of large-scale, randomized, controlled field trials investigating the efficacy of live oral typhoid vaccines (which led to licensure of Ty21a by the FDA). His post-licensure work with Haemophilus influenzae type b conjugate vaccine led to early introductions into the routine infant immunization schedule in Chile and Mali (West Africa).
In addition to his research accomplishments, "Levine is an outstanding colleague and leader," says Gary Nabel, Vaccine Research Center, NIAID. "His advice as an external scientific adviser has been invaluable to me personally as an external scientific adviser, and his recommendations have been critical in shaping the direction of our efforts at the Vaccine Research Center." Levine has a long track record in training individuals to pursue careers in basic, clinical and field vaccinology, and many have themselves since made major contributions to vaccinology.
Levine is a member on editorial boards of several journals and consults for many organizations including the World Health Organization, NIH, the Vaccine Research Center, Institute of Medicine, the U.S. Department of Defense, and multiple vaccine biotech companies and vaccine manufacturers. He was a member of the first Working Group of the Global Alliance for Vaccines and Immunization (GAVI Alliance) and was Co-Chair of the GAVI Task Force on Research and Development. He is a member of the Institute of Medicine of the National Academy of Sciences, the Association of American Physicians, the American Society of Clinical Investigation and the American Academy of Microbiology. He is past President of the American Epidemiological Society and the American Society of Tropical Medicine and Hygiene.
Levine's many honors include the Albert B. Sabin Gold Medal Award for lifetime achievement in vaccinology, selection by the editors of Baltimore Magazine as "Baltimorean of the Year," and award of the rank of "Grand Officer of the National Order of Mali" by the President of Mali for efforts in introducing new vaccines to the country's children. "More than any individual accomplishments, what stands out is the focus of Levine's work on the world's most vulnerable populations," Nabel further explains. "His efforts have focused on vaccine discovery for diseases that take their highest toll among children."
Among the 100 most cited researchers in immunology, Levine has 518 publications in refereed journals, 114 book chapters and is Senior Editor of the 4th edition of New Generation Vaccines, a textbook of research vaccinology. Rino Rappuoli, Novartis Vaccines and Diagnostics, describes Levine as "a giant in the field of vaccinology." He continues, "I cannot think of another person today that can match his lifetime contribution to vaccine discovery, vaccine development, and implementation of vaccination. He is not only a great scientist, but also a great entrepreneur of science that uses his science and passion to discover, develop, and make available to people new vaccines."
See more here:
The American Society for Microbiology honors Myron M. Levine
NEW YORK (AP) Facebook's new camera app makes sharing photos on the social media site a breeze. It's an improvement on posting photos using its main mobile app.
But other camera apps such as Instagram and Hipstamatic still reign supreme. Facebook Camera doesn't have the same level of addictiveness or the range of tools for sprucing up images.
Many people were perplexed when Facebook Inc. released its own camera app late last month, just weeks after snapping up the popular Instagram photo-sharing app for $1 billion.
The two apps, both free, have some similar features. Both have a scrollable feed of photos posted by your friends and other people you choose to follow. They also have a set of tools, or filters, which let you adjust contrast, color and other attributes.
But they are different enough that Facebook's camera app is more of a complement to the main Facebook app than a challenge to Instagram. Facebook's camera app is only available for Apple devices, while Instagram recently came out with a version that works on Android phones and tablet computers.
The app is easy to use with intuitive taps and swipes.
When you open it, you see a scroll of your friend's photos the ones you would see if you clicked the photo tab in the Facebook app or on Facebook's website for regular computers. Tap on a photo to see a larger version, optimized on your phone.
Above that is a bar that shows you the most recent pictures in your device's camera library all the photos you have stored on the iPhone or iPad. You can swipe down the feed of your friends' Facebook photos to see more of your own pictures, which you can then choose to post on Facebook.
You can comment, tag and 'like' photos, just as you can with the main app or website. You simply tap icons that hover over the photos. Change your mind? Just swipe away the comment box, and it disappears.
It is kind of a shock to suddenly see your whole photo library within a Facebook app. Before I got comfortable with the navigation, I was slightly paranoid I would accidently post a photo on Facebook without meaning to. But once I got used to the easy navigation within the app, that was less of a worry.
More here:
For some users, Facebooks Whats on your mind question does little to provoke. Instead, it feels like an obligatory, emotionless utterance from a stale marriage. I know you dont really care, Facebook.
And Im starting to doubt whether or not anyone else does either.
If you think that this (admittedly dramatic) ennui is uncommon among Facebook users, think again. A recent poll from Reuters/Ipsos found that 34% of Facebooker said they were spending less time on the site than they were just six months ago. Not only that, but almost 50% of users said that they just spend the same amount of time as they are used to spending. That leaves a pretty small margin of people who are so enthralled with the world of Facebook that they report spending more time on the site than they did six months ago.
When asked why they are spending less time on the site, the 34% had a pretty simple response: Its boring.
Boring; one of the worst things that can be said about anything that lives and dies by engagement. Lying, cheating, betrayal of trust all of these things are terrible, but can be overlooked if theres still some spice left. Its when you find that something has nothing left to offer thats the kiss of death.
Relationship parallels aside, Facebook has to be in a constant battle to stay fresh, interesting, and relevant. Sure, with 900+ million users, it would be easy to rest on the everyone has it, so everyone has to have it argument. But that only goes so far. Social media users have to be continually smacked in the mouth with something vital to their daily lives, their very existence something that they cant readily find anywhere else.
Facebook is most definitely ubiquitous, but it is old. Although it is (and always will be) a huge part of Facebook, the status update can only generate a finite amount of interest. Sure, some of your friends are witty and post hilarious commentary on everything from politics to movies to the battle of the sexes. And yes, others dazzle you with their interesting lives spent jumping from hostel to hostel in amazing European cities.
But lets face it most of your friends are boring when it comes to the written word. There is a very (very, very) short window for giving a shit when it comes to breakfast choices and canine anecdotes.
Facebook isnt oblivious they know this. And in the last year or so, Facebook has made some major changes to their product that has altered the user experience. Note that I said changes instead of upgrades, as not everyone has been happy with all the new features to hit the News Feed.
The Timelines, They Are A-Changin
Read the original post:
By Andrs Cardenal - June 6, 2012 | Tickers: ABT, LLY, GSK, JNJ, PFE | 0 Comments
Andrs is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited.
The stock market has become quite uncertain lately, the European crisis keeps getting worse every day, and economic data in the US is nothing to write home about. But investors need to keep their heads cool, volatility creates opportunity, and there is no necessity to assume high risks in order to capitalize on the opportunities created by economic hurdles. Big pharmaceutical companies are an attractive sector where solid businesses with strong cash flows and juicy dividend payments can be found in the current turmoil.
The pharmaceutical business is quite resilient in the face of economic problems, so these kind of companies will not go bankrupt even if there is another recession in the short term horizon. Solid balance sheets and big dividend payments are another characteristic that may become very coveted in times of economic uncertainty. And valuations are attractive too; many of these companies have been getting cheaper through the last years due to investors concerns about patent expirations and thelack of new blockbuster drugs.
Johnson & Johnson (NYSE: JNJ) is one of the safest companies in the sector, not only drugs are produced by this giant with a market cap of almost $170 billion, but Johnson & Johnson gets 40% of revenue from medical devices and diagnosis and another 23% from consumer products. The company is strongly diversified, both geographically and in terms of products, and although it has faced some quality control problems lately, Johnson & Johnson is a solid long term bet yielding a 3.9% in dividends and trading at a forward P/E ratio of 11.3.
Another strong business with an attractive dividend is Abbott(NYSE: ABT), which has reported strong quarterly profits lately. Abbott's plans are to separate the research-based pharmaceuticals from the medical products business in order to better focus research and capitalize growth opportunities, and this move could bring more visibility to the value of the companys operations. Abbott has a forward P/E ratio of 11.3 and the company yields 3.4% in dividends, which leaves ample upside room in shares of this global business.
Pfizer (NYSE: PFE) looks really attractive with a dividend yield of 4.1% and a forward P/E of 9.2. The company is facing increased generic competition in the context of a more risk conscious FDA, which slows down the development of new products. However, Pfizer has more than 90 drugs in its pipeline, although it will take time and effort to develop new products, Pfizer has the resources and the economic scale to go through this transition successfully. The pharmaceutical giant also has an unrivaled commercial and distribution team with presence all over the world, which is a key competitive advantage versus other firms in the industry.
Those willing to take some extra risk and venture into companies going through important patents expirations could consider a position in Eli Lilly (NYSE: LLY). The company is one of the most exposed to patent expirations, with more than 40% of current sales encountering generic competition between 2011 and 2013. But Eli Lilly is investing heavily to replenish its pipeline with research and development expenses in the neighborhood of 20% of sales, while most competitors spend around 15% of sales in R&D.
The company has the financial resources to continue investing heavily to develop new drugs, and acquisitions are always another possibility to increase revenues in the future, management is also focused on cutting expenses in order to go through the transition with strong profit margins. Investors in Eli Lilly should expect a volatile ride in the following years, but with a forward P/E below 11 and a dividend yield of 4.9% the stock is cheap and has a considerable potential for gains if management handles the patent loss problem in an effective manner.
There are even better dividend yields in big European pharma companies, and some of them look really attractive from a long term perspective, even considering competitive pressures and economic problems in the old continent. GlaxoSmithKline (NYSE: GSK) is a global powerhouse with a diversified product base and solid profitability ratios, the company is facing some patents expirations, but at the same time it has strong prospects in new drugs. Paying 5.1% in dividends and trading at a forward P/E barely above 10 the upside potential looks much better than downside risk in GlaxoSmithKline.
Excerpt from:
Wednesday, June 6, 2012
By David Bearman, M.D., Santa Barbara
Recently a Ninth Circuit Court of Appeals judge opined that Congress did not have cannabis in mind when it passed the Americans with Disabilities Act (ADA). And just how does that comport when the facts are that a person is actually disabled and benefits from this medicine and that the ADA calls for accommodation for the disabled? It appears as though we continue to have judges practicing medicine without a license. We have thousands of California doctors recommendingcannabis.
Many people who use medicinal cannabis are disabled under the ADA (they have phantom limb pain, quadriplegia, below-knee amputation, brain damage and the like). Cities must have such accommodations as curb cuts, must require elevators in new buildings. There are few more important accommodations than being able to get the treatment your doctor recommends or prescribes. Blocking access to that medicine is just obscene. Saying its fine to prevent access to an effective affordable medicine with few side effects, recommended by your doctor isheinous.
Read the original here:
WEDNESDAY, June 6 (HealthDay News) -- More than four decades after the last introduction of fresh treatments for tuberculosis, a new medication for multidrug-resistant strains of the global scourge has shown promise in a multinational trial.
Follow this link:
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--
New graduates of Ross University School of Medicine (RUSM) and Ross University School of Veterinary Medicine (RUSVM) will converge for a joint commencement ceremony on June 8 at the IZOD Center in the Meadowlands Complex in East Rutherford, N.J. William Karesh, DVM, a pioneer in the One Health movement, will deliver the keynote address.
The One Health initiative encourages collaboration between physicians, veterinarians, and other healthcare professionals to attain optimal health for people, animals, and the environment.
The health of people, animals, and the planet are inextricably linked, said Karesh, executive vice president for health and policy at Eco Health Alliance, a One Health-focused organization. I'm honored to address this years graduates of Ross University School of Medicine and Ross University School of Veterinary Medicine. These are the only two schools I am aware of that are putting the concept of One Health directly into its commencement ceremony, recognizing that physicians and veterinarians are equally integral to the future of health worldwide.
RUSM will confer Doctor of Medicine degrees on nearly 900 graduates, while RUSVM will award about 300 Doctor of Veterinary Medicine degrees. The commencement ceremony marks the end of an eventful year for both schools. RUSM graduates, under the leadership of dean and chancellor Joseph Flaherty, MD, landed a record number of residency positions. At RUSVM, newly appointed dean Elaine Watson, PhD has undertaken a strategic plan to develop the schools research agenda and postgraduate education programs.
Andrew Jeon, MD, MBA, president of DeVry Medical International (DMI), will also address the graduates. This will be Jeons first Ross graduation since joining DMI in October 2011. RUSM and RUSVM have a wonderful tradition of educating healthcare professionals to serve society. I have been both impressed and inspired by the energy, enthusiasm, and dedication of our students. It is a privilege to share this occasion with our 2012 graduates, said Jeon.
About Ross University School of Medicine
Ross University School of Medicine (RUSM) was founded in 1978 and is a provider of medical education offering a Doctor of Medicine degree program. Students begin their foundational studies in Dominica, West Indies, and complete their clinical training in teaching hospitals throughout the United States. RUSM graduates obtain more US residencies than graduates of any other medical school in the world. For more information about RUSM, visit http://www.rossu.edu/medical-school/.
About Ross University School of Veterinary Medicine
Ross University School of Veterinary Medicine (RUSVM), founded in 1982, is committed to educating highly-trained veterinarians to serve societys needs. RUSVM students complete their academic program on a technologically-advanced campus in St. Kitts, West Indies, before completing the final clinical year of the program in one of the over 20 AVMA-accredited U.S. veterinary schools affiliated with RUSVM. RUSVM is accredited by the St. Christopher & Nevis Accreditation Board (www.gov.kn) and the American Veterinary Medical Association Council on Education (www.avma.org) to offer the Doctor of Veterinary Medicine degree program. The RUSVM Veterinary Teaching Hospital is the only facility outside the U.S. and Canada accredited by the American Animal Hospital Association. For more information about RUSVM, visit http://www.rossu.edu/veterinary-school/.
More:
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--
Metagenics, Inc., a nutrigenomics and lifestyle medicine company focused on reducing chronic health conditions and improving health, announced that it is convening its first Lifestyle Medicine Summit on September 28-30, 2012, in Dana Point, Calif. This landmark professional education event will bring together prominent leaders in this rapidly growing field to share how science-based protocols can be effectively applied in clinical practice to reduce or reverse chronic health conditions and transform lives.
Around the world, the adoption of Western dietary habits, along with increasingly sedentary lifestyles and poorly managed stress, has led to an epidemic of chronic illnesses, such as type 2 diabetes, obesity, heart disease and autoimmune diseases. According to the Centers for Disease Control and Prevention, one out of two adult Americans has at least one chronic illness, and chronic diseases contribute to seven out of 10 deaths in the U.S.
Internationally known leaders in the field of lifestyle medicine, Jeffrey Bland, PhD, and Mark Hyman, MD, are confirmed speakers, as well as John Gray, PhD, bestselling author of Men Are from Mars, Women Are from Venus.
With the worldwide epidemic of chronic disease impacting our health and our economies, there's no debating that lifestyle medicine is a powerful force that cannot only help prevent, but also alleviate many of these illnesses, said Jeffrey Bland, PhD, FACS, CNS, chief science officer for Metagenics, Inc. The Lifestyle Medicine Summit is a unique opportunity to share advancements in lifestyle medicine and nutrigenomic approaches that address and help delay or reverse the onset of diabetes, obesity, heart disease, cancer, digestive issues, stress, inflammation, hormones, and cognitive disorders, such as Alzheimers and Parkinsons disease.
The Lifestyle Medicine Summit will take place at the St. Regis Monarch Beach Resort in Dana Point, Calif., on September 28-30, 2012.
Confirmed speakers include:
To learn more about the Metagenics University Lifestyle Medicine Summit and to register for the event, visit http://www.metagenics.com/2012summit or call 800-692-9400.
About Metagenics, Inc.
Metagenics, Inc. (www.metagenics.com) is a nutrigenomics and lifestyle medicine company focused on reducing chronic illness and improving health. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs to help their patients achieve a lifetime of good health. Metagenics scientific staffamong the largest in the nutrigenomics industryhas published more than 80 articles in peer-reviewed journals and has been awarded more than 50 international or domestic patents. The companys educational arm, Metagenics University, collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.
Here is the original post:
Metagenics Hosts First Lifestyle Medicine Summit to Address Growing Epidemic of Chronic Illness
June 6, 2012
By Gregg Bell - UW Director of Writing Click here to receive Gregg Bell Unleashed via email each week.
SEATTLE - One of the best days of Washington safety Greg Walker's22 years on Earth wasn't necessarily playing in the Holiday Bowl in December 2010, the Huskies' first postseason game in eight years. It wasn't starting his first college game as a freshman in September 2009, against LSU on national television at Husky Stadium.
It was March 2, 2012. That day, Washington's special teams player of the year for 2010 and `11 got his letter of acceptance from the fiercely selective Alpert Medical School of Brown University.
"One of the happiest days of my entire life," Walker told me with pride over the phone Tuesday morning.
That was just before he administered his final test as a biology teaching assistant. Saturday, he will walk in graduation with his fellow UW seniors at CenturyLink Field.
Walker could have returned for a fifth, redshirt-senior season of football. Instead, on August 9 he will begin orientation in medical school and start his journey to be a orthopedist or neurologist.
"Working with nerves, nerve endings and the central nervous system, that is `tight,'" Walker says.
So is this: Brown's Alpert Medical School is one of the most selective medical schools in the country. It reportedly has an acceptance rate of 3.2 percent of all applicants, enrolling approximately 120 students per class.
And this Husky is one of them.
Link:
General News. Unleashed: Special Congrats To These Special Grads
June 6, 2012
By Gregg Bell UW Director of Writing Click here to receive Gregg Bell Unleashed via email each week.
SEATTLE - One of the best days of Washington safety Greg Walker's 22 years on Earth wasn't necessarily playing in the Holiday Bowl in December 2010, the Huskies' first postseason game in eight years. It wasn't starting his first college game as a freshman in September 2009, against LSU on national television at Husky Stadium.
It was March 2, 2012. That day, Washington's special teams player of the year for 2010 and `11 got his letter of acceptance from the fiercely selective Alpert Medical School of Brown University.
"One of the happiest days of my entire life," Walker told me with pride over the phone Tuesday morning.
That was just before he administered his final test as a biology teaching assistant. Saturday, he will walk in graduation with his fellow UW seniors at CenturyLink Field.
Walker could have returned for a fifth, redshirt-senior season of football. Instead, on August 9 he will begin orientation in medical school and start his journey to be a orthopedist or neurologist.
"Working with nerves, nerve endings and the central nervous system, that is `tight,'" Walker says.
So is this: Brown's Alpert Medical School is one of the most selective medical schools in the country. It reportedly has an acceptance rate of 3.2 percent of all applicants, enrolling approximately 120 students per class.
And this Husky is one of them.
View original post here:
Football. Unleashed: Special Congrats To These Special Grads
The dean who was hired less than three years ago to fix problems at the University of Missouri School of Medicine has resigned as the school faces a federal fraud investigation.
Dr. Robert Churchill will leave the university in October to prevent further distractions surrounding the investigation of two of the school's radiologists, according to MU officials.
The radiologists, Dr. Kenneth Rall and Dr. Michael Richards, were dismissed Friday as part of the shake-up after an internal audit found the doctors illegally billed Medicare for services performed by resident doctors in training.
A law firm conducted the audit for the university after the U.S. Attorney's Office in Kansas City notified the school in November 2011 of its investigation into potential Medicare fraud. Rall stepped down as radiology department chairman in December, but stayed on as a professor.
"We were shocked and disappointed to learn about this, because any kind of fraud is entirely inconsistent with our health system's values, our mission, and our commitment to patient care," said Dr. Harold Williamson Jr., vice chancellor of the University of Missouri Health System, in a statement.
Both radiologists have clean records with the Missouri State Board of Registration for the Healing Arts, which licenses and regulates doctors.
Department of Justice spokesman Don Ledford said the agency doesn't discuss pending investigations.
In what it calls the early stages of its own investigation, school officials said they have not turned up any evidence that radiology patients were harmed.
Resident physicians are allowed to read patients' X-rays, but cannot bill Medicare for the procedure unless the images are also analyzed by a supervising doctor.
"We believe these two doctors sometimes claimed that they had actually completed this second review without actually looking at the image," Williamson said in the statement.
View original post here:
MU medical school dean resigns as school is under investigation
Updated at 1:50 p.m. 6/6/12 to correct the following: "Karmazin recently said he would do his best to prevent Liberty from gaining control of the company." Sirius XM CEO Mel Karmazin actually said if anyone were to gain control he would like them to pay a premium. TheStreet regrets the error.
Read the original: